2BB score and signals
Pyxis Oncology, Inc.’s current 2BB score is 16 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 7 | Very Low |
| Momentum | 28 | Weakening |
| Financial strength | 26 | Weak |
| Quality | 80 | Very Strong |
| Risk | 50 | Moderate |
Company facts
| Headquarters | Boston, Massachusetts, United States |
| Founded | 2018 |
| Employees | 56 |
| 52-week range | $1.03 – $5.55 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-02 | — | -0.2926 | — | $0.00 |
| 2026-08-19 | — | -0.3604 | — | $22,317.00 |
| 2026-05-14 | -0.37 | -0.3763 | $0.00 | $0.00 |
| 2026-03-23 | -0.29 | -0.3434 | $11.04M | $0.00 |
Related companies